Last week, BioCentriq attended Phacilitate’s Advanced Therapies Week, which was a great success and had thousands of attendees. Located in Miami, the venue held vendors and therapy developers from Tuesday through Friday, and BioCentriq was …

Newark, New Jersey – January 26, 2023 – BioCentriq, Inc.—a New Jersey-based, cell and gene therapy contract development and manufacturing organization (CDMO)—announced today that they’ve completed a study designed to test transfection of T-cells with …

Newark, New Jersey – January 17, 2023 – BioCentriq, Inc.—a New Jersey-based, cell and gene therapy contract development and manufacturing organization (CDMO)—announced today that they have successfully completed tech transfer of AVB-001 from client Avenge …

BioCentriq is announcing the release of a white paper published on January 16th, 2023, and titled Efficient, Large-Scale Transfection of T-Cells Using Flowfect® Technology. Transfection is an invaluable tool used in cell engineering applications to …

We’ve updated our brochure for you to learn all about BioCentriq. Explore all our capabilities, including our expertise, approach, manufacturing, process development, MS&T, facilities, and more. You’ll also get an introduction to our leadership team …

As BioCentriq advances toward becoming a leading CDMO, we’re proudly building a solid leadership team to carry out BioCentriq’s mission of bringing drug therapy products to patients worldwide. With combined decades of experience, our strong …

BioCentriq is thrilled to announce that Jackie Veivia-Panter is our new Chief Quality and Compliance Officer and has begun her role this week. Jackie has 30 years of experience in the pharmaceutical and cell therapy …

This month, BioCentriq hosted a webinar in collaboration with Phacilitate called Setting the Stage for Successful Manufacturing of Cell and Gene Therapies Webinar. It consisted of a panel of industry leaders giving much-needed lessons on …

Yesterday we celebrated the opening of our new GMP manufacturing facility, located adjacent to our pilot plant in South Brunswick. All employees were invited to join us at the Princeton Corporate Center in Monmouth Junction …

Topics Include the Bottlenecks in Personnel Capabilities and Facilities, Preclinical Pipeline Driving Capacity and Workforce Requirements, and Downstream Requirements  Newark, New Jersey– October 4, 2022 – BioCentriq, Inc.—a New Jersey-based, cell and gene therapy contract …

 BioCentriq added feeder cell irradiation capabilities to its impressive list of service offerings. In this article, we explain why we thought it was important to add these unique capabilities to our portfolio.  An Overview of …

This summer, BioCentriq ran its first internship program and recruited five talented students to work for ten weeks, allowing them to learn about the biotech industry, conduct research, and make lasting change within the company. …